Mycophenolate Mofetil
Mycophenolate mofetil suppresses lymphocyte activity and is commonly used to prevent organ rejection. It increases infection risk and can cause pregnancy loss and birth defects.
Key points
- After a transplant, stopping or switching mycophenolate without the transplant team can increase rejection risk.
- Pregnancy prevention, blood counts and kidney or liver checks may be required before and during treatment.
- Fever, severe infection symptoms, unexplained bruising or a serious allergic reaction needs prompt medical assessment.
Listings are for comparison only. Suitability and supply depend on clinician and pharmacy checks, stock, destination rules and prescription requirements.
What Mycophenolate Mofetil is used for
It is used with other immunosuppressants to prevent transplant rejection. Specialists may also use it for selected autoimmune diseases when the expected benefit justifies the risks.
How it works
Mycophenolate limits the production of lymphocytes involved in immune responses. This can protect a transplanted organ but also reduces the body’s ability to respond to infection.
Important safety checks
Pregnancy must be avoided under the required pregnancy-prevention plan. Blood counts and kidney and liver function may need monitoring. Vaccines, antacids and several other medicines require review. Do not stop treatment, change formulation or receive a live vaccine without advice from the treating team.
When to seek urgent care
Seek urgent help for fever with severe illness, breathing difficulty, facial swelling, widespread blistering rash, unusual bleeding, severe abdominal pain or persistent diarrhoea with weakness or dehydration.